10,000 transplant patients to be tracked for hidden heart risks
NCT ID NCT07349498
First seen Jan 18, 2026 · Last updated Jun 19, 2026 · Updated 25 times
Summary
This large observational study will follow 10,000 people who have had a stem cell transplant to see how often they develop heart problems like heart attacks, stroke, or heart failure. Researchers will collect medical data over time to better understand who is at risk and why. The goal is to improve long-term care for transplant survivors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese PLA General Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact
-
First Affiliated Hospital Xi'an Jiaotong University
RECRUITINGXi'an, Shaanxi, China
Contact
-
First Affiliated Hospital of Harbin Medical University
RECRUITINGHarbin, Heilongjiang, China
Contact
-
First Affiliated Hospital of Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang, China
Contact
-
First Affiliated Hospital of Zhejiang University
RECRUITINGHangzhou, Zhejiang, China
Contact
-
Hematology Hospital of Chinese Academy of Medical Sciences (Hematology Research Center of Chinese Academy of Medical Sciences)
RECRUITINGTianjin, Tianjin Municipality, China
Contact
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, China
Contact
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, China
Contact
-
Sun Yat-sen University Cancer Center, Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, China
Contact
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
Contact
-
Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
Contact
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
Contact
-
Xinqiao hospital of the third military medical university
RECRUITINGChongqing, Chongqing Municipality, China
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors identify which transplant patients are at higher risk for heart problems and guide better follow-up care.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve outcomes. Results may take years to gather and analyze.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.